“Cheaper and better”: Societal cost savings and budget impact of changing from systemic to intralesional pentavalent antimonials as the first-line treatment for cutaneous leishmaniasis in Bolivia

INTRODUCTION: Cutaneous leishmaniasis (CL), endemic in Bolivia, mostly affects poor people in rainforest areas. The current first-line treatment consists of systemic pentavalent antimonials (SPA) for 20 days and is paid for by the Ministry of Health (MoH). Long periods of drug shortages and a lack o...

Descripción completa

Detalles Bibliográficos
Autores principales: Eid Rodríguez, Daniel, San Sebastian, Miguel, Pulkki-Brännström, Anni-Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834242/
https://www.ncbi.nlm.nih.gov/pubmed/31693661
http://dx.doi.org/10.1371/journal.pntd.0007788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6834242/
https://www.ncbi.nlm.nih.gov/pubmed/31693661
http://dx.doi.org/10.1371/journal.pntd.0007788

Ejemplares similares